Modulation of Drug Transporters at the Blood-Brain Barrier
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A major challenge in the management of diseases of the central nervous system is the limited penetration of drugs into the brain. The structures responsible are the capillaries of the brain, whose endothelial cells form the so-called blood-brain barrier. Understanding the cellular and molecular structure as well as integrated function of this barrier is a prerequisite for successful drug delivery to the brain. Here we briefly review current knowledge about the active transport proteins (ABC and organic anion transporters) which function at the blood-brain barrier. We describe novel approaches to (1) modulate carrier protein function, and (2) circumvent the transporter-based carrier by targeted site-specific drug delivery systems, such as immunoliposome and nanoparticulate systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931
Furuno, T., Landi, M.-T., Ceroni, M., Caporaso, N., Bernucci, I., Nappi, G., Martignoni, E., Schaeffeler, E., Eichelbaum, M., Schwab, M., et al. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00004 · Cited by 178
Cited by
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
“Modern understanding of the transporter role and their contribution to the BBB was acquired in studies of P-gp (Fricker and Miller 2004).”
BackgroundDrug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617
The blood-brain barrier: structure, function and therapeutic approaches to cross it.
Tajes, M., Ramos-Fernández, E., Weng-Jiang, X., Bosch-Morató, M., Guivernau, B., Eraso-Pichot, A., Salvador, B., Fernàndez-Busquets, X., Roquer, J., & Muñoz, F. J. (2014) · Molecular Membrane Biology · doi:10.3109/09687688.2014.937468 · Cited by 380
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)
Lee, W., Glaeser, H., Smith, L. H., Roberts, R. L., Moeckel, G. W., Gervasini, G., Leake, B. F., & Kim, R. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411092200 · Cited by 365
The rise and rise of drug delivery
Rosen, H., & Abribat, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1721 · Cited by 296
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 296
Self-citationBlood Brain Barrier: A Challenge for Effectual Therapy of Brain Tumors
Bhowmik, A., Khan, R., & Ghosh, M. K. (2015) · BioMed Research International · doi:10.1155/2015/320941 · Cited by 291
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
K. Tiwari, A., Sodani, K., Dai, C.-L., R. Ashby, C., & Chen, Z.-S. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164048 · Cited by 211
“The ABCB1 transporter is present in the kidneys, intestine, placenta, liver, adrenal glands, and brain (primarily in the choroids plexus, astrocytes, microglia, and blood capillaries) [15, 16, 27].”
BackgroundCellular Elements of the Blood-Brain Barrier
Correale, J., & Villa, A. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0081-y · Cited by 194
“The multidrug resistance transporter P-glycoportein (P-gp) is an ATP-dependent efflux pump which prevents the passage of drugs and toxins across the BBB into the brain and may facilitate their transport from brain to blood [ 55 ].”
BackgroundOppenheim, H. A., Lucero, J., Guyot, A.-C., Herbert, L. M., McDonald, J. D., Mabondzo, A., & Lund, A. K. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-62 · Cited by 171
“In the luminal BBB endothelial cells, P-glycoprotein has been shown to inhibit transport of certain toxins and drugs across the BBB into the brain, as well as regulate chemical transport from brain to blood [19].”
BackgroundCritical Role of Actin in Modulating BBB Permeability
Lai, C.-H., Kuo, K.-H., & Leo, J. M. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.007 · Cited by 129
Zhang, W., Oh, J.-H., Zhang, W., Rathi, S., Le, J., Talele, S., Sarkaria, J. N., & Elmquist, W. F. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03574-1 · Cited by 19
“…anion trans-porting polypeptide 2 (OATP2), located on both luminal and abluminal sides of ECs at the BBB, is a bidirectional transporter, that is involved in the transport of 17β-estradiol-d-17β-glucuronide (E217βG) and dehydroepiandrosterone sulfate (DHEAS) out of the brain in rat models [80–82].”
Metadata
- Authors
- Fricker, G., & Miller, D. S.
- Venue
- Pharmacology
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 70
- Issue
- 4
- Pages
- 169-176
- ISSN
- 0031-7012 (ISSN-L)
- 1423-0313
- OpenAlex
- W2025035152
- Cited by
- 107
- References
- 3
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.